Symbol not found

0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)77.24M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$23.16 Million
Adjusted EPS-$0.09
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

YS Biopharma Co Ltd Stock, NASDAQ:YS

Daxing Biomedical Industry Park, Building No.2, 38 Yongda Road, Beijing, Beijing 102600
Cayman Islands
Phone: +852.9162.5199
Number of Employees:


YS Biopharma Co. Ltd. operates as a biopharmaceutical company, which is dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting rabies, Hepatitis B, shingles, influenza, and coronavirus. The company was founded in November, 2020 and is headquartered in Beijing, China.